World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
72
Citations
18633
World Ranking
19837
National Ranking
9881

Overview

Pierre Bordigoni is a researcher affiliated with Boston Children's Hospital in the United States, specializing in fields related to Medicine and Biochemistry, Genetics and Molecular Biology. Their research contributions emphasize hematology and genetics, focusing on topics within acute myeloid leukemia research, hematopoietic stem cell transplantation, and blood disorders and treatments.

Their published work includes studies relevant to childhood acute myeloblastic leukemia and post-transplantation relapse mechanisms. One notable paper is titled Assessment of chimerism and immunomodulation to prevent post-transplantation relapse in childhood acute myeloblastic leukemia: is it the right approach?, published in 2020 in the journal Pediatric Hematology and Oncology. This publication has been cited in the scientific community, reflecting ongoing interest in the area of transplant immunology and leukemia management.

Frequent coauthors in Bordigoni's research include:

  • Élie Cousin
  • Emmanuel Oger
  • Jean-Hugues Dalle
  • Yves Bertrand
  • Sophie Pertuisel

Bordigoni's work is prominently found in the publication venue:

  • Pediatric Hematology and Oncology

Their main fields of study cover:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

Subfields of study focused on by Bordigoni include:

  • Hematology
  • Genetics

The main research topics of interest are:

  • Acute Myeloid Leukemia Research
  • Hematopoietic Stem Cell Transplantation
  • Blood disorders and treatments

Best Publications

  • Clinical spectrum of X-linked hyper-IgM syndrome

    Jacov Levy;Teresa Espanol-Boren;Carolin Thomas;Alain Fischer

  • Donor Lymphocyte Infusion in the Treatment of First Hematological Relapse After Allogeneic Stem-Cell Transplantation in Adults With Acute Myeloid Leukemia: A Retrospective Risk Factors Analysis and Comparison With Other Strategies by the EBMT Acute Leukemia Working Party

    Christoph Schmid;Myriam Labopin;Arnon Nagler;Martin Bornhäuser

  • Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease

    Françoise Bernaudin;Gérard Socie;Mathieu Kuentz;Sylvie Chevret

  • Randomized Trial of Bone Marrow Versus Lenograstim-Primed Blood Cell Allogeneic Transplantation in Patients With Early-Stage Leukemia: A Report From the Société Française de Greffe de Moelle

    Didier Blaise;Mathieu Kuentz;Cecile Fortanier;Jean Henri Bourhis

  • Factors associated with outcomes of unrelated cord blood transplant: Guidelines for donor choice

    Eliane Gluckman;Vanderson Rocha;William Arcese;Gérard Michel

  • Pediatric mastocytosis is a clonal disease associated with D816V and other activating c-KIT mutations.

    Christine Bodemer;Christine Bodemer;Olivier Hermine;Olivier Hermine;Fabienne Palmérini;Ying Yang

  • Long-term effect of bone-marrow transplantation for childhood-onset cerebral X-linked adrenoleukodystrophy

    Elsa G Shapiro;W. Krivit;L. Lockman;I. Jambaqué

  • Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP-deficiency) versus type 2 (XLP-2/XIAP-deficiency)

    Jana Pachlopnik Schmid;Jana Pachlopnik Schmid;Danielle Canioni;Despina Moshous;Despina Moshous;Fabien Touzot

  • Analysis of risk factors for myelodysplasias, leukemias and death from infection among patients with congenital neutropenia. Experience of the French Severe Chronic Neutropenia Study Group.

    Jean Donadieu;Thierry Leblanc;Brigitte Bader Meunier;Mohamed Barkaoui

  • WHIM syndromes with different genetic anomalies are accounted for by impaired CXCR4 desensitization to CXCL12.

    Karl Balabanian;Bernard Lagane;José Luis Pablos;Lysiane Laurent

  • Allogeneic bone marrow transplantation for lysosomal storage diseases

    P.M. Hoogerbrugge;O.F. Brouwer;P. Bordigoni;G. Cornu

  • Treatment of Adenovirus Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

    Pierre Bordigoni;Anne-Sophie Carret;Véronique Venard;Francis Witz

  • Anti–B-Cell Monoclonal Antibody Treatment of Severe Posttransplant B-Lymphoproliferative Disorder: Prognostic Factors and Long-Term Outcome

    Malika Benkerrou;Jean-Philippe Jais;Véronique Leblond;Anne Durandy

  • Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985-2000.

    Reinhard A. Seger;Tayfun Gungor;Bernd H. Belohradsky;Stephane Blanche

  • Human mesenchymal stem cells license adult CD34+ hemopoietic progenitor cells to differentiate into regulatory dendritic cells through activation of the Notch pathway.

    Yin Ping Li;Sophie Paczesny;Sophie Paczesny;Evelyne Lauret;Sonia Poirault

  • Idiopathic disseminated bacillus Calmette-Guérin infection: a French national retrospective study.

    J L Casanova;S Blanche;J F Emile;E Jouanguy

  • Identification of New Prognosis Factors from the Clinical and Epidemiologic Analysis of a Registry of 229 Diamond-Blackfan Anemia Patients

    TN Willig;CM Niemeyer;T Leblanc;C. Tiemann

  • Unrelated cord blood transplantation for childhood acute myeloid leukemia: a Eurocord Group analysis

    Gerard Michel;Vanderson Rocha;Sylvie Chevret;William Arcese

  • Phase I-II trial of a monoclonal anti-tumor necrosis factor alpha antibody for the treatment of refractory severe acute graft-versus-host disease.

    P Herve;M Flesch;P Tiberghien;J Wijdenes

  • In a novel form of IFN-gamma receptor 1 deficiency, cell surface receptors fail to bind IFN-gamma.

    Emmanuelle Jouanguy;Stéphanie Dupuis;Annaïck Pallier;Rainer Döffinger

Frequent Co-Authors

Mauricette Michallet
Mauricette Michallet University of Helsinki
Gérard Socié
Gérard Socié Université Paris Cité
André Baruchel
André Baruchel Hôpital Robert-Debré
Alain Fischer
Alain Fischer Collège de France
Eliane Gluckman
Eliane Gluckman Université Paris Cité
Stéphane Blanche
Stéphane Blanche Université Paris Cité
Michel Attal
Michel Attal Janssen (Belgium)
Jean Donadieu
Jean Donadieu University of Paris-Saclay
Norbert Ifrah
Norbert Ifrah Grenoble Alpes University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're interested in healthcare but not fully committed to the traditional path of studying medicine, there are alternative degrees and careers to consider. For those aspiring to become a registered nurse, choosing the easiest rn program to get into can help streamline the admission process and get you started in the nursing profession faster.

Some nursing schools also have less rigorous entry requirements—many are now nursing schools that don't require teas test scores, making it easier for non-traditional students or career changers.

Another flexible career pathway is medical billing and coding. This field often requires only a certificate or associate degree, and there are several online medical billing and coding schools that accept fafsa, making financial aid accessible while you study remotely.

If you're interested in the business side of healthcare, pursuing a healthcare administration degree online is another accelerated option. These programs prepare you for management roles in hospitals, clinics, and other healthcare organizations.

Best Scientists Citing Pierre Bordigoni

Trending Scientists

Recently Published Articles